[HTML][HTML] Walking test outcomes in adults with genetic neuromuscular diseases: a systematic literature review of their measurement properties
N Hadouiri, I Fournel, C Thauvin-Robinet… - European Journal of …, 2024 - ncbi.nlm.nih.gov
Walking test outcomes in adults with genetic neuromuscular diseases: a systematic literature
review of their measurement properties - PMC Back to Top Skip to main content NIH NLM Logo …
review of their measurement properties - PMC Back to Top Skip to main content NIH NLM Logo …
Outcome measures frequently used to assess muscle strength in patients with myotonic dystrophy type 1: a systematic review
Measurement of muscle strength is fundamental for the management of patients with
myotonic dystrophy type 1 (DM1). Nevertheless, guidance on this topic is somewhat limited …
myotonic dystrophy type 1 (DM1). Nevertheless, guidance on this topic is somewhat limited …
Quantifying Muscular Atrophy via Medical Imaging: Applications in Aging and Muscular Dystrophy
DAM Fuentes - 2022 - search.proquest.com
Abstract In the United States, there are about 55 million older adults, accounting for 16% of
the population. This percentage is expected to rise to 22% by 2040. Skeletal muscle function …
the population. This percentage is expected to rise to 22% by 2040. Skeletal muscle function …
revised figure below. The authors apologize for this error.
I Knak - ncbi.nlm.nih.gov
Figure 3. Agreement between the objective muscle strength, balance and functional mobility
measurements and the subjective GRS. Area under the curve (Y-axis) is reported for both …
measurements and the subjective GRS. Area under the curve (Y-axis) is reported for both …
[PDF][PDF] A6 Cardiac, skeletal and respiratory methods and outcome measures of choice to evaluate muscle strength of patients with Myotonic Dystrophy Type 1: A …
Myotonic dystrophy type 1 (DM1) is the most common form of muscular dystrophy in adults
with a prevalence of 1 in 3,000 to 8,000 individuals worldwide [1, 2]. DM1 is an autosomal …
with a prevalence of 1 in 3,000 to 8,000 individuals worldwide [1, 2]. DM1 is an autosomal …